Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ASPH | Q12797 | 1/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 3/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | RXRA | P19793 | 1/20 | 0.31 |
| ▸ | RXRB | P28702 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29617167 | 1.00 | ASPH (0.34) | ASPHPDK2ALOX5NOTUMKDM4E | |
| SCHEMBL29405016 | 1.00 | ASPH (0.34) | ASPHPDK2ALOX5NOTUMKDM4E | |
| SCHEMBL9455649 | 0.97 | KMT2A (0.34) | ASPHPDK2ALOX5NOTUMKDM4E | |
| SCHEMBL28922371 | 0.84 | PDK2 (0.30) | PDK2 | |
| SCHEMBL3471311 | 0.83 | NOTUM (0.33) | ASPHALOX5NOTUMKDM4EALDH1A1 | |
| SCHEMBL1099586 | 0.78 | PDK2 (0.38) | PDK2ALOX5NOTUMKDM4EALDH1A1 | |
| SCHEMBL29415487 | 0.77 | PDK2 (0.42) | PDK2KDM4EALDH1A1HSD17B10KMT2A | |
| SCHEMBL9221863 | 0.77 | PDK2 (0.37) | PDK2ALOX5NOTUMKDM4EALDH1A1 | |
| SCHEMBL3272491 | 0.76 | ALOX5 (0.34) | ALOX5KDM4EALDH1A1RXRARXRB | |
| SCHEMBL9220858 | 0.76 | PDK2 (0.36) | PDK2ALOX5NOTUMKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 269 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240052104-A1 | DICARBONYL HALIDES, POLYMER COMPOSITIONS AND FILMS MADE THEREFROM | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2024-02-15 | — | — | US | claimed |
| CN-102436164-B | The intermediate transfer element of phosphate ester polyimide containing | Xerox Corp. (US) Patent Dept. 020 Xerox Square 100 Clinton Avenue Rochester New (US) | 2016-04-20 | — | — | CN | claimed |
| US-9034423-B2 | Method of making a fuser member | XEROX CORPORATION (US) | 2015-05-19 | — | — | US | claimed |
| US-20140178579-A1 | METHOD OF MAKING A FUSER MEMBER | XEROX CORPORATION (US) | 2014-06-26 | — | — | US | claimed |
| US-20140171588-A1 | COMPOSITION FOR FLEXIBLE SUBSTRATE AND FLEXIBLE SUBSTRATE FORMED FROM THE SAME | CHI MEI CORPORATION (TW) | 2014-06-19 | — | — | US | claimed |
| EP-2092807-B1 | COMPOSITE ORGANIC ENCAPSULANTS | CDA PROC LTD LIABILITY COMPANY (US) | 2013-04-17 | — | — | EP | claimed |
| US-20120049123-A1 | PHOSPHATE ESTER POLYIMIDE CONTAINING INTERMEDIATE TRANSFER MEMBERS | XEROX CORPORATION (US) | 2012-03-01 | — | — | US | claimed |
| US-8029901-B2 | Polyaryl ether copolymer containing intermediate transfer members | XEROX CORPORATION (US) | 2011-10-04 | — | — | US | claimed |
| US-20100279214-A1 | POLYARYL ETHER COPOLYMER CONTAINING INTERMEDIATE TRANSFER MEMBERS | XEROX CORPORATION (US) | 2010-11-04 | — | — | US | claimed |
| US-7745516-B2 | Composition of polyimide and sterically-hindered hydrophobic epoxy | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-06-29 | — | — | US | claimed |
| EP-0758000-B1 | Polyimide films from pyromellitic dianhydride and 2,2'-bis(perfluoroalkoxy)benzidines as alignment layers for liquid crystal displays | DU PONT (US) | 2001-12-19 | — | — | EP | claimed |
| US-6316170-B2 | COATING, EXPOSURE, DEVELOPMENT AND HEAT TREATMENT | KABUSHIKI KAISHA TOSHIBA (JP) | 2001-11-13 | — | — | US | claimed |
| US-20010006767-A1 | Developing solution and method of forming polyimide pattern by using the developing solution | YOSHIAKI KAWAMONZEN | 2001-07-05 | — | — | US | claimed |
| US-6066400-A | Polyimide biasable components | XEROX CORPORATION (US) | 2000-05-23 | — | — | US | claimed |
| US-5759442-A | Polyimide alignment film from 2,2-BIS (3,4-dicarboxyphenyl)--hexafluoropropane dianhydride and ortho-substituted aromatic diamines for active matrix liquid crystal displays | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1998-06-02 | — | — | US | claimed |
| US-5731404-A | Polyimide film from pyromellitic dianhydride and a bis(4-aminophenoxy) aromatic compound as an alignment layer for liquid crystal displays | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1998-03-24 | — | — | US | claimed |
| US-5670609-A | FILMS WITH LIQUID CCRYSTAL STRUCTURE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1997-09-23 | — | — | US | claimed |
| EP-0772074-A1 | Polyimide film from pyromellitic dianhydride and bis(4-aminophenoxy) aromatic compound as an alignment layer for liquid crystal displays | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1997-05-07 | — | — | EP | claimed |
| EP-0768559-A1 | Polyimide alignment film from 2,2-bis(3,4-dicarboxyphenyl)hexafluoropropane, dianhydride and ortho-substituted aromatic diamines for active matrix liquid crystal displays | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1997-04-16 | — | — | EP | claimed |
| EP-0758000-A2 | Polyimide films from pyromellitic dianhydride and 2,2'-bis(perfluoroalkoxy)benzidines as alignment layers for liquid crystal displays | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1997-02-12 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240052104-A1 | DICARBONYL HALIDES, POLYMER COMPOSITIONS AND FILMS MADE THEREFROM | PUF60, PICALM, PARG | ASPH 618/4885PDK2 3405/4885ALOX5 1327/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.